RaQualia Pharma Inc. (TYO:4579)
Japan flag Japan · Delayed Price · Currency is JPY
714.00
-29.00 (-3.90%)
Nov 18, 2026, 10:30 AM JST

RaQualia Pharma Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,6553,2403,3403,7143,6752,345
Short-Term Investments
1593149250313
Cash & Short-Term Investments
4,8143,2433,3413,7633,9252,658
Cash Growth
35.87%-2.93%-11.21%-4.13%47.67%25.79%
Receivables
5601,9286896036021,205
Inventory
166159167147810
Prepaid Expenses
26616519318810890
Other Current Assets
21618714825517940
Total Current Assets
6,0225,6824,5384,9564,8224,003
Property, Plant & Equipment
406436529573391299
Long-Term Investments
6965986071,3061,020897
Goodwill
3,4903,7003,865---
Other Intangible Assets
253237302433
Long-Term Deferred Tax Assets
6464785--
Other Long-Term Assets
1211-2
Total Assets
10,70410,5149,6556,8716,2575,234

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7173595412845
Accrued Expenses
605869546063
Current Portion of Long-Term Debt
511512512122-
Current Portion of Leases
957869644221
Current Income Taxes Payable
174320221178237230
Other Current Liabilities
46234257272441
Total Current Liabilities
9571,2751,187389493400
Long-Term Debt
1,7552,1382,651399-
Long-Term Leases
17117121825116717
Long-Term Deferred Tax Liabilities
----216
Other Long-Term Liabilities
313528738915
Total Liabilities
2,9143,6194,084752760448

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
3,9523,2402,7202,6672,2652,256
Additional Paid-In Capital
4,1423,4302,9102,8572,4552,446
Retained Earnings
-266227-4544977349
Comprehensive Income & Other
-38-2-14146435
Shareholders' Equity
7,7906,8955,5716,1195,4974,786
Total Liabilities & Equity
10,70410,5149,6556,8716,2575,234

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2,5322,8993,45036622038
Net Cash (Debt)
2,282344-1093,3973,7052,620
Net Cash Growth
362.14%---8.31%41.41%26.69%
Net Cash Per Share
88.1814.30-5.04157.22176.57124.93
Filing Date Shares Outstanding
26.0326.0221.8421.6221.620.96
Total Common Shares Outstanding
26.0324.4621.8421.6220.9820.95
Working Capital
5,0654,4073,3514,5674,3293,603
Book Value Per Share
299.22281.91255.10282.98262.05228.43
Tangible Book Value
4,2753,1631,6696,0895,4734,753
Tangible Book Value Per Share
164.21129.3276.43281.60260.90226.86